查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446444

羊膜穿刺针市场规模、份额、趋势分析报告：按类型、程序、最终用途、地区和细分市场预测，2024-2030

Amniocentesis Needle Market Size, Share & Trends Analysis Report By Type (100 to 150 mm, Smaller Than 100 mm, and Larger Than 150 mm), By Procedure, By End-use, By Region, and Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

羊膜穿刺针市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球羊膜穿刺针市场规模将达到2.9735亿美元，复合年增长率为6.85%。

这一增长可归因于多种因素，包括医疗技术的进步、遗传性疾病盛行率的上升推动产前诊断需求的增加以及微创技术的持续发展。羊膜穿刺针的需求量很大，因为它们对于识别潜在风险至关重要。然而，妇产科领域对羊膜穿刺术后早期妊娠流产的迫切关注。

全球遗传疾病数量的增加，导致产前诊断对羊膜穿刺针等精密工具的需求显着增加。此类遗传性疾病的日益流行凸显了对胎儿潜在问题的准确和早期检测方法的迫切需求。由于遗传疾病对健康的严重影响，对更好的产前护理的需求不断增长，凸显了羊膜穿刺针等先进工具的重要性。例如，MJH Life Sciences 的 2022 年报告强调了全球日益沉重的遗传疾病负担，指出每年约有 30 万婴儿出生时患有镰状细胞病，占世界人口的 5.5%。做作的。

女性普遍倾向将生育延后到高龄生产。随着母亲年龄的增长，胎儿染色体异常的风险增加，使得羊膜穿刺成为重要的诊断工具。羊膜穿刺术后早期流产的发生是妇产科领域的重要关注点。釐清这现象背后的因素极为重要。研究报告了不同的发生率，有些研究显示发生率高达 10% 左右。因此，这与年龄相关的因素极大地推动了对羊膜穿刺针的需求。

此外，孕妇糖尿病和高血压等慢性疾病的盛行率不断上升，增加了对更全面的产前筛检的需求。根据全球妇女医学图书馆2021年发表的研究论文估计，根据世界卫生组织的标准，全球约16.9%的怀孕在怀孕期间受到高血糖的影响。由于肥胖率上升、母亲老化以及筛检和诊断标准的变化，这些病理的发生率正在上升。此外，医学专业人士越来越认识到早期检测遗传疾病的重要性。因此，经常建议面临这些健康挑战的女性进行羊膜穿刺术，并提供评估胎儿健康的重要方法。

羊膜穿刺针市场报告亮点

  • 2023年，100-150mm细分市场占据最大市场占有率。这可能是由于最佳长度可以满足产前手术中不同的临床要求。
  • 由于对准确可靠的产前诊断的需求不断增长以及遗传异常盛行率的增加，羊膜穿刺术在 2023 年的手术领域中占据主导地位。
  • 2023 年的最终使用领域主要由医院领域主导，因为医院提供包括羊膜穿刺术在内的全面产前服务，并且是这些针头的主要使用者。
  • 由于先进的医疗基础设施、产前检测意识的提高、先进医疗技术采用率的提高以及遗传异常盛行率的上升，北美地区在 2023 年占据了最大的市场份额。
  • 市场参与者已采取多项策略倡议来扩大产品覆盖范围并提高不同地区的可用性。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章羊膜穿刺针市场：变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 羊膜穿刺针市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 羊膜穿刺针市场：类型估算与趋势分析

  • 定义和范围
  • 类型市场占有率，2018年及2030年
  • 细分仪表板
  • 按类型分類的全球羊膜穿刺针市场展望
  • 2018-2030年市场规模、预测与趋势分析

第五章羊膜穿刺针市场：治疗估算与趋势分析

  • 定义和范围
  • 2018年及2030年治疗市场占有率
  • 细分仪表板
  • 按程序分類的全球羊膜穿刺针市场展望
  • 2024-2030年市场规模、预测与趋势分析

第六章 羊膜穿刺针市场：最终用途估计与趋势分析

  • 定义和范围
  • 2018 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 以最终用途分類的全球羊膜穿刺针市场展望
  • 2024-2030年市场规模、预测与趋势分析

第七章羊膜穿刺针市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商形势
    • Smith's Medical
    • Biopsybell Srl
    • Integra LifeSciences
    • Laboratoire CCD
    • Cook Medical
    • RI.MOS. Srl
    • CooperSurgical
    • Medline
    • Rocket Medical
    • Becton Dickinson and Company
Product Code: GVR-4-68040-190-1

Amniocentesis Needle Market Growth & Trends:

The global amniocentesis needle market size is anticipated to reach USD 297.35 million by 2030, expanding at a CAGR of 6.85%, based on a new report by Grand View Research, Inc. This growth can be attributed to several factors like advancements in healthcare technology, a rising prevalence of genetic disorders prompting increased demand for prenatal diagnosis, and the continuous development of minimally invasive techniques. Amniocentesis needles are in high demand as they are essential for identifying potential risks. However, there is a pressing concern within the fields of obstetrics and gynecology regarding early pregnancy loss following amniocentesis.

The rise in genetic disorders worldwide is significantly boosting the demand for precise tools such as amniocentesis needles in prenatal diagnostics. This rising prevalence of genetic conditions highlights the pressing need for accurate and early detection methods for potential issues in unborn babies. The importance of advanced tools like amniocentesis needles is underscored by the growing demand for better prenatal care due to the serious health implications of genetic disorders. For instance, a 2022 report from MJH Life Sciences highlighted the escalating global burden of genetic diseases, revealing that around 300,000 babies are born with sickle cell disease annually, affecting nearly 5% of the world's population.

The trend of women delaying childbirth to older ages has gained prevalent traction. Advanced maternal age is inherently linked to a promoted risk of chromosomal abnormalities in the fetus, rendering amniocentesis comes in as a crucial diagnostic tool. The occurrence of early abortion following amniocentesis is a significant concern within the fields of obstetrics and gynecology. It's crucial to uncover the factors that contribute to this phenomenon. Studies have reported varying incidence rates, with some suggesting rates as high as around 10%. Consequently, this age-related factor significantly propels the demand for amniocentesis needles.

Furthermore, the increasing prevalence of chronic diseases such as diabetes and hypertension among expectant mothers has increased the demand for more comprehensive prenatal screening. According to a 2021 research paper published by The Global Library of Women's Medicine, it is estimated that approximately 16.9% of pregnancies worldwide are affected by hyperglycemia during pregnancy, as per WHO criteria. The incidence of such conditions is on the rise, attributed to factors like the increasing obesity rate, advanced maternal age, and changes in screening and diagnostic criteria. Moreover, healthcare professionals increasingly acknowledge the importance of early detection of genetic disorders. Thus, amniocentesis is frequently recommended for women dealing with these health challenges, providing a crucial means to assess fetal health.

Amniocentesis Needle Market Report Highlights:

  • In 2023, the 100-150 mm segment accounted for the largest market share. This can be attributed due to its optimal length, which caters to diverse clinical requirements in prenatal procedures
  • The amniocentesis procedures segment dominated the procedure segment in 2023 owing to the rising demand for accurate and reliable prenatal diagnosis and increasing prevalence of genetic abnormalities
  • Hospitals segment dominated the end use segment in 2023 as they offer comprehensive prenatal services, including amniocentesis, making them key users of these needles
  • The North American region held the largest share of the market in 2023 due to advanced healthcare infrastructure, increased awareness about prenatal testing, higher adoption rates of advanced medical technologies, and a rising prevalence of genetic disorders
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Procedure
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Amniocentesis Needle Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of gestational diabetes
      • 3.2.1.2. Increasing prevalence of genetic disorders and chromosomal abnormalities
      • 3.2.1.3. Rise in prenatal testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk and invasiveness
      • 3.2.2.2. Alternative non-invasive testing
  • 3.3. Amniocentesis Needle Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Amniocentesis Needle Market: Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. 100 to 150 mm
    • 4.1.2. Larger Than 150 mm
    • 4.1.3. Smaller Than 100 mm
  • 4.2. Type Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Amniocentesis Needle Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. 100 to 150 mm
      • 4.5.1.1. 100 to 150 mm market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Smaller Than 100 mm
      • 4.5.2.1. Smaller Than 100 mm market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Larger Than 150 mm
      • 4.5.3.1. Larger Than 150 mm market estimates and forecast 2018 to 2030s (USD Million)

Chapter 5. Amniocentesis Needle Market: Procedure Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Amniocentesis Procedures
    • 5.1.2. Amnioreduction Procedures
    • 5.1.3. Fetal Blood Transfusion
    • 5.1.4. Amnioinfusion Procedure
    • 5.1.5. Cordocentesis Procedure
  • 5.2. Procedure Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Amniocentesis Needle Market by Procedure Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 5.5.1. Amniocentesis Procedures
      • 5.5.1.1. Amniocentesis procedures market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Amnioreduction Procedures
      • 5.5.2.1. Amnioreduction procedures market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Fetal Blood Transfusion
      • 5.5.3.1. Fetal blood transfusion market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Amnioinfusion Procedure
      • 5.5.4.1. Amnioinfusion procedure market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Cordocentesis Procedure
      • 5.5.5.1. Cordocentesis Procedure market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Amniocentesis Needle Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Diagnostics Centers
    • 6.1.3. Clinics
    • 6.1.4. Others
  • 6.2. End-use Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Amniocentesis Needle Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Diagnostic Centers
      • 6.5.2.1. Diagnostic centers market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Clinics
      • 6.5.3.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Amniocentesis Needle Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement scenario
      • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement scenario
      • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Smith's Medical
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Biopsybell Srl
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Integra LifeSciences
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Laboratoire CCD
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cook Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. RI.MOS. Srl
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CooperSurgical
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Medline
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Rocket Medical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Becton Dickinson and Company
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of regulatory bodies for different countries
  • Table 2 Key companies' product launches
  • Table 3 Key companies' merger and acquisitions
  • Table 4 Key companies' collaboration
  • Table 5 Other strategic initiatives of companies
  • Table 6 North America amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 9 North America amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 12 U.S. amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 15 Canada amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 19 Europe amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 UK amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 22 UK amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 25 Germany amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 France amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 27 France amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 28 France amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 30 Italy amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 31 Italy amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Spain amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 33 Spain amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 34 Spain amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Norway amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 37 Norway amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 39 Sweden amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 40 Sweden amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Denmark amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 42 Denmark amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 43 Denmark amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 50 Japan amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 52 China amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 53 China amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 India amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 55 India amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 56 India amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 59 Australia amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 62 South Korea amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Thailand amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 64 Thailand amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 65 Thailand amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 68 Latin America amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 69 Latin America amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 71 Brazil amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 72 Brazil amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 74 Mexico amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 75 Mexico amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 78 Argentina amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 85 South Africa amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 91 UAE amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 94 Kuwait amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Amniocentesis needle market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement process
  • Fig. 4 Primary research pattern
  • Fig. 5 Amniocentesis needle market snapshot, 2023 (USD Million)
  • Fig. 6 Segment snapshot, USD Million
  • Fig. 7 Competitive landscape snapshot
  • Fig. 8 Penetration & growth prospect mapping, by product
  • Fig. 9 Market driver analysis (Current & future impact)
  • Fig. 10 Market restraint analysis (Current & future impact)
  • Fig. 11 Amniocentesis needle market, type outlook key takeaways (USD Million)
  • Fig. 12 Amniocentesis needle market: type movement analysis (USD Million), 2023 & 2030
  • Fig. 13 100 to 150 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Smaller than 100 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Larger than 150 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Amniocentesis needle market: procedure movement analysis (USD Million), 2023 & 2030
  • Fig. 17 Amniocentesis procedures market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Amnioreduction procedures market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Fetal blood transfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Amnioinfusion procedure market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cordocentesis procedure market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Amniocentesis needle market, end use outlook key takeaways (USD Million)
  • Fig. 23 Amniocentesis needle market: End use movement analysis (USD Million), 2023 & 2030
  • Fig. 24 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Diagnostics centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Amniocentesis needle market: Regional key takeaways (USD Million)
  • Fig. 29 Amniocentesis needle market: Regional outlook, 2023 & 2030, USD Million
  • Fig. 30 North America amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 China amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 List of key emerging company's/technology disruptors/innovators